Drug treatment in Europe

AFRICA

AMERICAS

ASIA

EUROPE

OCEANIA

PRIMARY DRUG AMONG PERSONS TREATED FOR DRUG PROBLEMS IN EUROPE

2016 (or latest year available)

Country / Territory

Source

Treatment
Year ***

Distribution of main drugs in percentages*

Treatment
Provided **

Data
Primarily
Reflect

Cannabis

Cocaine

ATS

Tranquilizers
and
Sedatives

Hallucinogens

Solvents
and
Inhalants

Other †

Albania

ARQ

2015

23.5%

33.1%

0.4%

1.5%

0.0%

0.0%

0.0%

472

 

Andorra

ARQ

2016

50.7%

15.0%

2.9%

20.0%

0.0%

0.0%

0.0%

140

k

Austria

ARQ

2015

24.2%

5.9%

4.5%

2.1%

0.1%

0.0%

0.2%

4,400

a, e, f

Belarus

ARQ

2016

 

 

 

 

 

 

 

14,000

 

Belgium

ARQ

2015

31.2%

19.4%

11.3%

9.5%

0.3%

0.1%

0.0%

12,922

a

Bosnia and Herzegovina

ARQ

2010-2015

4.4%

0.0%

0.8%

0.3%

0.3%

0.0%

0.0%

455

j

Bulgaria

ARQ

2015

5.7%

2.1%

8.6%

3.3%

0.1%

0.1%

2.2%

7,070

a, k

Croatia

ARQ

2016

17.4%

1.3%

2.2%

2.3%

0.2%

0.1%

3.1%

7,202

 

Cyprus

ARQ

2015

58.1%

9.1%

4.1%

0.4%

0.1%

0.0%

0.2%

1,304

c, e, f, h

Czechia

ARQ

2015

9.6%

0.2%

44.8%

1.7%

0.1%

0.1%

 

5,874

a

Denmark

ARQ

2014

70.9%

5.5%

6.9%

1.4%

0.1%

0.1%

2.0%

4,705

e, f

Estonia

ARQ

2016

1.2%

0.3%

4.3%

0.3%

0.3%

0.0%

0.0%

346

e, f

Finland

EMCDDA

2015

20.7%

0.0%

18.1%

8.4%

0.5%

0.2%

0.5%

656

 

France

ARQ

2014

48.1%

6.8%

1.1%

3.0%

0.4%

0.1%

1.1%

116,263

j

Germany

ARQ

2015

41.0%

6.0%

17.2%

0.0%

0.2%

0.1%

3.2%

83,617

a, k

Gibraltar

ARQ

2008

23.8%

66.7%

0.0%

4.8%

0.0%

0.0%

0.0%

41

d

Greece

ARQ

2015

4.7%

1.7%

0.1%

0.6%

0.1%

 

 

12,997

a

Macedonia (TFYR)

ARQ

2009

6.8%

1.3%

0.0%

0.0%

0.0%

0.0%

0.0%

1,212

 

Hungary

ARQ

2016

56.7%

2.7%

18.9%

3.5%

4.6%

0.4%

8.3%

4,098

a

Iceland

ARQ

2007

33.3%

16.7%

50.0%

0.0%

0.0%

0.0%

0.0%

1,800

a

Ireland

ARQ

2015

28.2%

10.4%

1.2%

10.4%

0.1%

0.2%

0.9%

9,892

k, c

Italy

ARQ

2016

11.1%

17.8%

0.3%

0.4%

0.1%

0.0%

0.6%

143,273

c

Latvia

ARQ

2016

22.1%

0.7%

16.4%

5.9%

0.3%

2.8%

1.1%

879

 

Liechtenstein

ARQ

2016

 

 

 

 

 

 

 

31

a, d

Lithuania

ARQ

2016

2.0%

0.1%

2.9%

1.7%

0.0%

1.9%

16.0%

5,259

 

Luxembourg

ARQ

2015

 

 

 

 

 

 

 

1,200

a, h

Malta

ARQ

2015

8.6%

15.4%

1.4%

0.1%

0.1%

0.2%

3.4%

1,829

a

Moldova (Republic of)

ARQ

2011/ 2013***

64.7%

0.0%

1.3%

0.2%

0.0%

0.3%

0.0%

1,053

 

Monaco

ARQ

2013

83.9%

1.8%

0.0%

5.4%

0.0%

1.8%

0.0%

56

 

Montenegro

ARQ

2015

0.0%

0.5%

0.0%

3.6%

0.0%

0.0%

0.0%

670

b

Netherlands

ARQ

2015

34.8%

23.4%

6.2%

4.5%

0.0%

 

0.1%

31,115

a, e, f, l

Norway

ARQ/Govt.

2015

19.8%

0.8%

9.9%

6.9%

0.2%

0.0%

 

17,925

a, c

Poland

ARQ

2015

28.0%

2.1%

36.2%

3.9%

0.2%

0.3%

0.3%

9,013

 

Portugal

ARQ

2015

32.4%

11.1%

0.4%

0.7%

0.1%

0.0%

 

3,295

 

Romania

ARQ

2016

48.5%

1.0%

1.2%

1.4%

0.1%

1.1%

19.6%

3,544

a

Russian Federation

ARQ

2016

5.7%

0.0%

2.9%

 

 

4.5%

9.3%

496,000

a

Serbia

ARQ

2016

2.0%

0.4%

0.4%

5.2%

0.3%

0.1%

 

1,432

 

Slovakia

ARQ

2016

22.7%

1.1%

38.1%

3.3%

0.0%

1.4%

6.7%

3,253

 

Slovenia

ARQ

2015

8.3%

2.5%

0.6%

8.6%

0.0%

0.0%

 

2,907

k, e, f,

Spain

ARQ

2015

33.2%

36.7%

2.0%

2.3%

0.0%

0.0%

0.2%

47,308

 

Sweden

ARQ

2015

13.7%

1.1%

8.0%

17.2%

1.0%

0.3%

 

24,488

 

Switzerland

 

2014

33.2%

11.5%

2.9%

2.3%

0.3%

 

0.8%

3,194

k

Turkey

ARQ

2015

6.0%

1.8%

2.8%

0.6%

0.3%

1.6%

12.7%

10,884

d

Ukraine

ARQ

2015

                       

 

 

 

 

 

 

51,939

j

United Kingdom

ARQ

2015

24.8%

11.8%

4.8%

2.8%

0.3%

0.2%

0.3%

101,919

a

Total

   

 

 

 

 

 

 

 

1,251,932

 

Average

   

           26.0%

    8.4%

    8.2%

    3.8%

                                 0.3%

    0.5%

      2.7%

 

 

EE&SEE

   

           16.8%

    3.8%

    1.9%

    1.8%

                                 0.1%

    0.7%

      4.7%

595,933

 

WE&CE

   

           29.4%

 10.1%

 10.5%

    4.4%

                                 0.3%

    0.4%

      1.9%

655,999

 

 

*      Definitions of treatment interventions, recording practices (including counting rules) and methods for determining the primary drug of abuse differ from country to country; percentages may fail to add up to 100 per cent owing to incomplete reporting, gaps in identifying primary drug of abuse and treatment for multiple drugs. In cases where the total of the reported values by drug type exceeded the reported value for all treatment, the percentages are expressed as a proportion of the total.

**    Figures may reflect number of persons or treatment episodes depending on the Member State; figures exclude alcohol and nicotine.

***  If multiple years are given, the second year specified is for the number of people treated (second to last column).

†    In addition to miscellaneous and unspecified drugs, the category "Other" includes substances not under international control.

  1. Whole country
  2. Geographically limited reporting (eg the Capital city)
  3. Publicly funded treatment
  4. NGO/ privately funded treatment
  5. Inpatient/ hospitalization modality
  6. Outpatient modality
  7. Limited subpopulation (eg prison, youth, etc)
  8. Opioid substitution treatment (eg methadone)
  9. First-time treatment entrants (not returning clients)
  10. Treatment admissions (not persons)
  11. Partial coverage (geographical/treatment type)
  12. Prisons excluded
  13. Treatment entrants only